TargetMol

RM65

Product Code:
 
TAR-T28545
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T28545-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28545-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28545-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
RM65 is an arginine methyltransferase inhibitor.
CAS:
947508-41-0
Formula:
C34H32N2O4S2
Molecular Weight:
596.76
Purity:
0.98
SMILES:
CC(SC1c2ccccc2Oc2ccccc12)C(=O)NCCNC(=O)C(C)SC1c2ccccc2Oc2ccccc12

References

1. Ben-Gera J, Klement E, Khinich E, Stram Y, Shpigel NY. Comparison of the efficacy of Neethling lumpy skin disease virus and x10RM65 sheep-pox live attenuated vaccines for the prevention of lumpy skin disease - The results of a randomized controlled field study. Vaccine. 2015 Sep 11;33(38):4837-42. doi: 10.1016/j.vaccine.2015.07.071. Epub 2015 Aug 1. PubMed PMID: 26238726. 2. Abutarbush SM, Hananeh WM, Ramadan W, Al Sheyab OM, Alnajjar AR, Al Zoubi IG, Knowles NJ, Bachanek-Bankowska K, Tuppurainen ES. Adverse Reactions to Field Vaccination Against Lumpy Skin Disease in Jordan. Transbound Emerg Dis. 2016 Apr;63(2):e213-9. doi: 10.1111/tbed.12257. Epub 2014 Aug 6. PubMed PMID: 25098267. 3. Brenner J, Bellaiche M, Gross E, Elad D, Oved Z, Haimovitz M, Wasserman A, Friedgut O, Stram Y, Bumbarov V, Yadin H. Appearance of skin lesions in cattle populations vaccinated against lumpy skin disease: statutory challenge. Vaccine. 2009 Mar 4;27(10):1500-3. doi: 10.1016/j.vaccine.2009.01.020. Epub 2009 Jan 30. PubMed PMID: 19186204. 4. Spannhoff A, Machmur R, Heinke R, Trojer P, Bauer I, Brosch G, Sch?le R, Hanefeld W, Sippl W, Jung M. A novel arginine methyltransferase inhibitor with cellular activity. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4150-3. Epub 2007 Jun 3. PubMed PMID: 17570663.